RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes.
Gulei D, Moisoiu V, Kegyes D, Drula R, Iluta S, Tigu AB, Nistor M, Jitaru C, Bancos A, Rotariu P, Popovici C, Dima D, Tomai R, Rus I, Constantinescu C, Munteanu R, Cenariu D, Sezerman U, Zdrenghea M, Cermak J, Einsele H, Ghiaur G, Tomuleasa C.
Gulei D, et al. Among authors: nistor m.
J Cell Mol Med. 2024 Sep;28(18):e70078. doi: 10.1111/jcmm.70078.
J Cell Mol Med. 2024.
PMID: 39334509
Free PMC article.